Tag: dom3

Thunderstorm Asthma

Thunderstorm Asthma: St Emlyn’s

In the UK this weekend there are warnings out regarding Thunderstorm Asthma. This is a rare but well described phenomena when patients who are previously known to be grass pollen allergic (e.g. hayfever) suffer asthma

JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s

We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the RECOVERY trial has released the

March 2021 Podcast Round Up (episode 187). St Emlyn’s

A discussion about all the latest from the St Emlyn’s blog, including a hot off the press article about vaccine induced thrombocytopenic thrombosis and the new FRCEM revision guide.  Simon and Iain also talk about the latest results from

VITT

Post-vaccine headache in the Emergency Department: what you need to know. St Emlyn’s

I am sure you all saw the recent MHRA press release and guidance, discussing the issue of a possible link between the AstraZeneca COVID19 vaccine and a rare type of thrombotic condition of Vaccine induced

#FOAMed quality

Assessing on-line medical education resources. A podcast with Peter Brindley

Last year I was contacted by Peter Brindley, Leon Byker and Brent Thoma to collaborate on a paper for the Journal of the Intensive Care Society. The aim was to help people understand a little

thromboprophylaxis

JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s

The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for these patients as it was

February 2021 podcast

February 2021 Round Up Podcast. St Emlyn’s

Our regular podcast round up from February 2021. Iain and Simon highlight the key learning points from this month on the St Emlyn’s blog and podcast. Please remember to subscribe to the podcast on iTunes/Google

convalescent plasma

JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s

The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial quite extensively and thus far

Colchicine

Colchicine does not improve mortality in COVID19. St Emlyn’s

This week the RECOVERY trial has released the first results from the Colchicine arm of the trial. We await the pre-print and the peer reviewed paper, but we are already very familiar with the trial

tocilizumab

Tocilizumabulous? A special offer on IL-6 with Tocilizumab.

It’s very rare we produce three instalments on one particular drug for one particular condition, and certainly not within such a short time frame. However, tocilizumab has been worth it. Maybe not the one intervention